Cellular abnormalities of blood vessels as targets in cancer.
about
Modes of resistance to anti-angiogenic therapyRole of pericytes in skeletal muscle regeneration and fat accumulationContrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vesselsAnticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients: evidence and hypothesisTumor-Induced Local and Systemic Impact on Blood Vessel FunctionAnti-angiogenesis or pro-angiogenesis for cancer treatment: focus on drug distributionTargeting angiogenesis in gynecologic cancersIntertwined regulation of angiogenesis and immunity by myeloid cellsEndothelial cell-pericyte interactions stimulate basement membrane matrix assembly: influence on vascular tube remodeling, maturation, and stabilizationTumor endothelial cellsDelivery of gene silencing agents for breast cancer therapySingle-cell analysis of endothelial morphogenesis in vivo.Mural cell associated VEGF is required for organotypic vessel formationBiomarkers Discovery for Colorectal Cancer: A Review on Tumor Endothelial Markers as Perspective CandidatesMolecular Connections between Cancer Cell Metabolism and the Tumor MicroenvironmentAdaptation to antiangiogenic therapy in neurological tumorsEndosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endotheliumProteomic analysis of vascular endothelial growth factor-induced endothelial cell differentiation reveals a role for chloride intracellular channel 4 (CLIC4) in tubular morphogenesisNotch pathway modulation on bone marrow-derived vascular precursor cells regulates their angiogenic and wound healing potentialDeletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancerBlood vessels as targets in tumor therapyIdentification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cellsVicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activitiesIntegrins in cancer: biological implications and therapeutic opportunitiesHigh-Resolution Multispectral Optoacoustic Tomography of the Vascularization and Constitutive Hypoxemia of Cancerous TumorsRecent developments in dynamic contrast-enhanced ultrasound imaging of tumor angiogenesis.Non-invasive imaging for studying anti-angiogenic therapy effects.Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.Three-dimensional reconstruction of neovasculature in solid tumors and basement membrane matrix using ex vivo X-ray microcomputed tomographyVessel caliber--a potential MRI biomarker of tumour response in clinical trials.Rap1 Spatially Controls ArhGAP29 To Inhibit Rho Signaling during Endothelial Barrier Regulation.Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events.Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.Emerging data with antiangiogenic therapies in early and advanced non-small-cell lung cancer.Potential role of vascular targeted therapy to combat against tumor.The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinomaMolecular regulation of tumor angiogenesis and perfusion via redox signaling.Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.
P2860
Q24608005-15F81DE8-F07A-4369-B829-BC2419AAEDE5Q24634546-F09D6FD6-D5ED-4426-B672-76C9B8E21632Q24644150-B6DCC48A-68A6-48E5-A450-E325FA28D622Q26740812-21C8789F-D476-441D-A709-4BFBA5A30803Q26771958-2FE6715C-C348-48A9-B678-3CA4D16FF675Q26796955-1AC34669-E956-4127-A95C-4CCD4DDEA1E0Q26824766-D1529346-2CD2-475A-B039-A2DC82B3BACEQ26830418-A3B843C1-3A79-4002-990E-A17BFB71B382Q26852191-11FB239B-65AD-4816-84E2-D59E8408BDB9Q26995733-94420AAA-BDC6-42B9-BF8B-9744BD6E832CQ27008706-D9117C0C-567C-414B-90DE-747FB7FA7531Q27342874-10D0C3C7-A99C-45F1-9BB0-8971837C1433Q27348757-6E221DDE-D984-4E01-9D6E-2F7B990FBFE5Q28071510-F9182C3B-FC6E-447B-8808-D22A232E5D66Q28081657-C07378E1-40FA-41A6-8270-1C635EC4DE24Q28082908-63D1CBC7-2233-4E75-AF35-26EF9E4EF2A6Q28247711-C0B7AA68-47F4-4F96-A1F9-D3F34BC4E142Q28278230-5CD5026C-892F-4677-ADF2-40402341B3A4Q28474088-AAD5B75B-0D8B-406D-AC3C-B43AEF9D6450Q28505630-6E5D4DAD-B1E4-401E-9E57-D83AD2A18804Q28590737-4A1D45BC-67AA-4DB9-9F75-910E62F94353Q28650438-C49CCACE-F5BA-4178-93C9-0C2F11CFEB75Q28751757-60FE502E-CB83-4EB6-AEDB-19222D213882Q29614536-6BB7AD6A-3388-498B-B915-87D6E9716307Q30374396-E04636DE-0DBD-41D2-81B7-9882A35763FBQ30419728-FD88029F-0F1F-4A8B-A9F5-A04090D8211DQ30447988-DCA947FD-1DE5-4EAE-94C8-495194743562Q30542073-BCF4041E-5366-4C7D-998E-FE6FB7107E87Q30579125-BDF09FA0-C712-4841-937B-614BABD728E9Q30588927-88D36923-8723-4BC0-A52A-756F737C6399Q30651792-BA58D6B5-9C5C-4E95-BE03-4603EFE60704Q30655135-F35AF747-E147-4473-9599-E0552FDFC1F8Q31028410-FBF78C32-3BDE-454D-9D75-7B9AD7F2EBCAQ33410375-184C0079-2397-45B4-BE89-A0846C6D0711Q33429478-D6F2DE50-73D1-4BD5-BB0E-AC65A1DE0BFCQ33470615-51F2FFCB-34A5-4705-96B2-E142687D6AAFQ33514437-114C9400-A380-4660-B74A-8F1A3425D363Q33572306-5597A5C8-6793-4178-B207-B87C2B681EE0Q33592374-23947F47-88F7-454E-A938-C47D5CE0BE51Q33633839-23332CF8-7E70-44C2-88D4-B266457EE272
P2860
Cellular abnormalities of blood vessels as targets in cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cellular abnormalities of blood vessels as targets in cancer.
@ast
Cellular abnormalities of blood vessels as targets in cancer.
@en
type
label
Cellular abnormalities of blood vessels as targets in cancer.
@ast
Cellular abnormalities of blood vessels as targets in cancer.
@en
prefLabel
Cellular abnormalities of blood vessels as targets in cancer.
@ast
Cellular abnormalities of blood vessels as targets in cancer.
@en
P2093
P1476
Cellular abnormalities of blood vessels as targets in cancer.
@en
P2093
Donald M McDonald
Hiroya Hashizume
Peter Baluk
P304
P356
10.1016/J.GDE.2004.12.005
P577
2005-02-01T00:00:00Z